3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Melanoma
6
Carcinoma, Renal Cell
6
Squamous Cell Carcinoma of Head and Neck
5
Carcinoma, Non-Small-Cell Lung
5
Clear-cell metastatic renal cell carcinoma
3
Neoplasm Metastasis
2
Lung Neoplasms
2
Hodgkin Disease
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Turcot syndrome
1
Solid Tumors
1
Skin Neoplasms
1
Sarcoma, Kaposi
1
Sarcoma
1
Recurrence
1
Rare Tumour
1
Post-Acute COVID-19 Syndrome
1
Pancreatic Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms
1
Mouth Neoplasms
1
Medulloblastoma
1
Lung Diseases, Interstitial
1
Liver Neoplasms
1
Fibrolamellar hepatocellular carcinoma
1
Ependymoma
1
Interventions
Nivolumab
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Post-Acute COVID-19 Syndrome
×
Nivolumab
×
Clear all
NCT05597800
2022-10-28
LUNGVIR
Universita di Verona
Phase 2
Not yet recruiting
105 enrolled